arrow
V

Valentina Mazzotta

luigi sacco hospital
H指数:26
被引数:3,462

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical outcomes, safety and predictors of disease progression in high-risk COVID-19 outpatients treated with nirmatrelvir/ritonavir: an Italian multicenter retrospective cohort study (PRIMA study)
2026-09-210
OAAI
Role of direct-acting antivirals in people with HIV-associated non-Hodgkin lymphoma and concomitant HCV infection: A study on behalf of the Fondazione Italiana Linfomi

直接抗病毒药物在合并HCV感染的HIV相关非霍奇金淋巴瘤患者中的作用:意大利淋巴瘤基金会研究

2026-09-060
PRE
Obesity at antiretroviral therapy initiation and long-term risk of cardiovascular disease, cancer, or death in people with HIV in Italy: a prospective cohort study

在意大利,HIV感染者抗逆转录病毒治疗启动时的肥胖与心血管疾病、癌症或死亡的长期风险:一项前瞻性队列研究

2026-08-010
PRE
Ion Torrent Genexus as a Fast and Reliable Solution for HIV-1 Drug Resistance Testing: Comparison with the GeneStudio S5 Workflow

Ion Torrent Genexus作为HIV-1药物耐药性检测的快速可靠解决方案:与GeneStudio S5工作流的比较

2026-07-230
OA
Rapid achievement of protective cabotegravir concentrations in a real-world HIV PrEP cohort

在真实世界HIV PrEP队列中快速达到保护性卡博特格韦浓度

2026-07-010
OAAI
TTV Viremia and Immune Responses Following Vaccination Against Mpox and Dengue Viruses

TTV病毒血症及针对猴痘病毒和登革病毒的疫苗接种后免疫应答

2026-05-190
OAAI
Association of HIV Envelope Susceptibility Signatures to Broadly Neutralizing Antibodies and Presence of p24 CTL Epitopes During Acute HIV-1 Infection

HIV包膜对广谱中和抗体易感性与急性HIV-1感染期间p24 CTL表位存在的关系

2026-05-010
PRE
Low Prevalence of HCV Infection Among MSM in an Intervention for HCV Micro-Elimination in Rome Urges a Focus on High-Risk Behaviours

罗马HCV微消除干预中男男性行为人群HCV感染率低,亟需关注高风险行为

2026-03-030
OAAI
Salivary cortisol in long COVID: a marker of broader stress system and circadian rhythm dysregulation

长新冠患者的唾液皮质醇:更广泛的应激系统和昼夜节律失调的标志

2026-01-060
OAAI
Improved HIV-1 Subtyping Accuracy Using near Full-Length Sequencing: A Comparison of Common Tools

使用近全长测序提高HIV-1分型准确性:常用工具的比较

2025-12-020
OAAI
Mental Health, Stigma and Risk Perception Among Early Adopters of HIV PrEP with LA Cabotegravir in Italy: A Multicenter Cross-Sectional and Implementation Study

心理健康、污名及风险认知:意大利使用长效卡博特格韦的HIV PrEP早期采纳者多中心横断面与实施研究

2025-12-010
OAAI
Supporting equitable booster strategies: one-year real-world immunogenicity data in people with HIV (PWH) receiving different variant-adapted COVID-19 vaccines

支持公平的加强针策略:人类免疫缺陷病毒感染者(PWH)接种不同变体适应型COVID-19疫苗后一年的真实世界免疫原性数据

2025-11-070
OAAI
Determinants of non-compliance with additional booster doses of the SARS-CoV-2 vaccine in people living with HIV (PWH): An observational study based on a behavioral and epidemiological survey in Rome (Italy)

人类免疫缺陷病毒感染者(HIV感染者)未接受SARS-CoV-2疫苗追加加强针的影响因素:一项基于罗马(意大利)行为学和流行病学调查的观察性研究

2025-11-060
OAAI
Inflammatory Milieu and Specific T-Cell Response Observed Three Months and One Year After SARS-CoV-2 Infection in Long COVID Subjects

长期新冠患者感染SARS-CoV-2后三个月和一年观察到的炎症微环境及特异T细胞应答

2025-10-270
OAAI